BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present

Clinical Endocrinology

Volumn 79, Issue 5, 2013, Pages 733-738

  Marotta, Vincenzo ^a   Guerra, Anna ^b   Zatelli, Maria C ^c   Degli Uberti, Ettore Ciro ^c   Di Stasi, Vincenza ^b   Faggiano, Antongiulio ^a,d   Colao, Annamaria ^a   Vitale, Mario ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE;

ADULT; ARTICLE; CANCER STAGING; CLINICAL FEATURE; CYTOLOGY; DISEASE COURSE; FEMALE; HASHIMOTO DISEASE; HISTOLOGY; HUMAN; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PYROSEQUENCING; SEQUENCE ANALYSIS; THYROID CARCINOMA;

ADULT; AGED; CARCINOMA; CARCINOMA, PAPILLARY; FEMALE; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS;

EID: 84877891173     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12194     Document Type: Article

References (33)

1. Jemal, A., Siegel, R., Xu, J., et al,. (2010) Cancer statistics, 2010. CA: A Cancer Journal for Clinicians, 60, 277-300.
2. Antonaci, A., Consorti, F., Mardente, S., et al,. (2009) Clinical and biological relationship between chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Oncology Research, 17, 495-503.
3. Lee, J.-H., Kim, Y., Choi, J.-W., et al,. (2012) The association between papillary thyroid carcinoma and histologically-proven Hashimoto's thyroiditis: a meta-analysis. European Journal of Endocrinology, 168, 343-349.
4. Zhang, L., Li, H., Ji, Q.H., et al,. (2012) The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease. BMC Cancer, 12, 610.
5. Gasbarri, A., Sciacchitano, S., Marasco, A., et al,. (2004) Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis. British Journal of Cancer, 91, 1096-1104.
6. Prasad, M.L., Huang, Y., Pellegata, N.S., et al,. (2004) Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC. Histopathology, 45, 39-46.
7. Marotta, V., Guerra, A., Sapio, M.R., et al,. (2011) RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint. European Journal of Endocrinology, 165, 499-507.
8. Rhoden, K.J., Unger, K., Salvatore, G., et al,. (2006) RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. Journal of Clinical Endocrinology and Metabolism, 91, 2414-2423.
9. Sapio, M.R., Guerra, A., Marotta, V., et al,. (2011) High growth rate of benign thyroid nodules bearing RET/PTC rearrangements. Journal of Clinical Endocrinology and Metabolism, 96, E916-919.
10. Xing, M., (2007) BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocrine Reviews, 28, 742-762.
11. Nucera, C., Porrello, A., Antonello, Z.A., et al,. (2010) B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci U S A, 107, 10649-10654.
12. Nucera, C., Lawler, J., &, Parangi, S., (2011) BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression. Cancer Research, 71, 2417-2422.
13. Knauf, J.A., Sartor, M.A., Medvedovic, M., et al,. (2011) Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFbeta signaling. Oncogene, 30, 3153-3162.
14. Marotta, V., Sapio, M.R., Guerra, A., et al,. (2011) BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma. Expert Opinion on Medical Diagnostics, 5, 277-290.
15. Guerra, A., Marotta, V., Deandrea, M., et al,. (2012) BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma. Endocrine, doi: 10.1007/s12020-012- 9843-4 (in press).
16. Kim, K.H., Suh, K.S., Kang, D.W., et al,. (2005) Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis. Pathology International, 55, 540-545.
17. Rosai, J., Carcangiu, M.L., &, De Lellis, R.A., (1992) Tumors of the thyroid gland. In:, J. Rosai, L. H. Sobin, eds. Atlas of Tumor Pathology, Third Series, Fascicle 5. Armed Forces Institute of Pathology, Washington, DC, 49-62.
18. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, A. Trotti, eds. AJCC Cancer Staging Manual, 7th edn. Springer, New York, 87-96.
19. Guerra, A., Sapio, M.R., Marotta, V., et al,. (2012) The Primary Occurrence of BRAFV600E Is a Rare Clonal Event in Papillary Thyroid Carcinoma. Journal of Clinical Endocrinology and Metabolism, 97, 517-524.
20. Guerra, A., Fugazzola, L., Marotta, V., et al,. (2012) A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome. Journal of Clinical Endocrinology and Metabolism, 97, 2333-2340.
21. Guerra, A., Sapio, M.R., Marotta, V., et al,. (2011) Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application. Endocrine Journal, 58, 31-38.
22. Hanahan, D., &, Weinberg, R.A., (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
23. Baker, J.R. Jr, (1995) The immune response to papillary thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 80, 3419-3420.
24. Fiore, E., Rago, T., Latrofa, F., et al,. (2011) Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocrine-Related Cancer, 18, 429-437.
25. Singh, B., Shaha, A.R., Trivedi, H., et al,. (1999) Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126, 1070-1076.; discussion 1076-1077.
26. Yoon, Y.H., Kim, H.J., Lee, J.W., et al,. (2012) The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. European Archives of Oto-Rhino-Laryngology, 269, 1013-1017.
27. Loh, K.C., Greenspan, F.S., Dong, F., et al,. (1999) Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 84, 458-463.
28. Kim, S.K., Song, K.H., Lim, S.D., et al,. (2009) Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid, 19, 137-141.
29. Vesely, M.D., Kershaw, M.H., Schreiber, R.D., et al,. (2011) Natural innate and adaptive immunity to cancer. Annual Review of Immunology, 29, 235-271.
30. Vitale, M., (2013) SEREX: a promising approach for identification of thyroid cancer serological biomarkers. Clinical endocrinology, doi: 10.1111/cen.12161
31. Qian, B.Z., &, Pollard, J.W., (2010) Macrophage diversity enhances tumor progression and metastasis. Cell, 141, 39-51.
32. Salzano, M., Russo, E., Postiglione, L., et al,. (2012) Interferon-gamma inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells. Journal of Endocrinology, 215, 439-444.
33. Ugolini, C., Basolo, F., Proietti, A., et al,. (2007) Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma. Thyroid, 17, 389-393.